Edition:
United Kingdom

Basilea Pharmaceutica AG (BSLN.S)

BSLN.S on Swiss Exchange

39.16CHF
20 Aug 2019
Change (% chg)

-- (--)
Prev Close
CHF39.16
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
54,756
52-wk High
CHF62.70
52-wk Low
CHF33.46

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 59.47 -0.815
Jun '18 46.62 -2.074
FY 2017 Dec '17 49.51 0.111
Jun '17 41.17 -1.899
 
*Note: Units in Millions ofSwiss Francs
**Note: Units in Swiss Francs

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-19 2 67.65 89.30 46.00 46.00
Year Ending Dec-19 7 133.53 134.90 130.00 136.04
Year Ending Dec-20 6 165.25 187.50 149.54 162.54
Earnings (per share)
Quarter Ending Dec-19 2 -1.57 -0.13 -3.00 -1.56
Quarter Ending Dec-20 1 -1.30 -1.30 -1.30 -0.37
Year Ending Dec-19 7 -2.85 -1.83 -3.80 -1.24
Year Ending Dec-20 6 0.29 2.79 -1.30 2.13
Sales and Profit Figures in Swiss Franc (CHF);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.38 32.67
P/E High - Last 5 Yrs. -- 147.67 47.29
P/E Low - Last 5 Yrs. -- 47.98 23.87
Beta 1.31 1.09 0.89
Price to Sales (TTM) 12.39 49.45 7.91
Price to Book (MRQ) -- 10.14 5.38
Price to Tangible Book (MRQ) -- 13.74 6.71
Price to Cash Flow (TTM) -- 55.94 24.37
% Owned Institutions -- 3.66 1.45

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg 1.21 0.09 1.38
Dividend 5 Year Growth Rate -- 0.78 4.54
Payout Ratio(TTM) -- 7.01 40.24

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 38.49 205.61 12.23
Sales (TTM) vs TTM 1 Yr. Ago 35.14 49.06 7.74
Sales - 5 Yr. Growth Rate -0.50 22.79 10.88
EPS (MRQ) vs Qtr. 1 Yr. Ago 31.18 75.23 42.99
EPS (TTM) vs TTM 1 Yr. Ago 28.13 -- --
EPS - 5 Yr. Growth Rate -- 11.92 10.32
Capital Spending - 5 Yr. Growth Rate -34.31 9.20 14.84

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 2.78 2.23 2.21
Current Ratio (MRQ) 2.98 3.59 3.03
LT Debt to Equity (MRQ) -- 18.57 10.20
Total Debt to Equity (MRQ) -- 31.18 14.55
Interest Coverage (TTM) -17.38 -44.60 29.80

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 92.31 56.08 52.23
Gross Margin - 5 Yr. Avg. -- 60.28 50.41
EBITD Margin (TTM) -45.22 -- --
EBITD - 5 Yr. Avg -84.28 -110.38 13.13
Operating Margin (TTM) -48.03 -184.16 6.90
Operating Margin - 5 Yr. Avg. -89.66 -126.82 8.94
Pre-Tax Margin (TTM) -56.97 -174.91 6.11
Pre-Tax Margin - 5 Yr. Avg. -92.75 -132.58 9.23
Net Profit Margin (TTM) -57.44 -181.60 2.74
Net Profit Margin - 5 Yr. Avg. -93.21 -136.95 5.60
Effective Tax Rate (TTM) -- 22.42 22.40
Effective Tax Rate - 5 Yr. Avg. -- 15.43 22.74

Efficiency

  Company industry sector
Revenue/Employee (TTM) 318,667 7,668,822 887,145,550
Net Income/Employee (TTM) -183,042 533,853 101,828,525
Receivable Turnover (TTM) 27.34 6.28 5.93
Inventory Turnover (TTM) 0.45 1.88 3.36
Asset Turnover (TTM) 0.24 0.32 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -13.74 6.40 11.17
Return on Assets - 5 Yr. Avg. -14.90 5.49 12.34
Return on Investment (TTM) -17.70 8.94 14.48
Return on Investment - 5 Yr. Avg. -18.35 6.81 16.02
Return on Equity (TTM) -- 10.07 15.78
Return on Equity - 5 Yr. Avg. -78.01 8.38 17.01
  1 Year 3 Year 5 Year
Sales % 25.91 16.67 -0.50
EPS (TTM) % 16.82 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Basilea Pharmaceutica AG

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -1.17 -4.81 99 99
13 Week -1.24 -5.17 99 95
26 Week -5.55 -11.79 99 97
52 Week 5.61 -6.73 99 71
YTD 9.37 -2.83 99 73
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 26.45%
# of Holders: 56
Total Shares Held: 3,142,479
3 Mo. Net Change: -39,906
# New Positions: 0
# Closed Positions: 2
# Increased Positions: 11
# Reduced Positions: 7
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.